Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,163,771
+$295,719 QoQ
Shares Held
1,804
-11.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#2,426
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCNB CORP holds $15,058,607 across 8 Drug Manufacturers - General names. LLY ranks #4 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
26,283 | $3,377,365 | |
| 2 | JNJ |
Johnson & Johnson
|
12,559 | $3,189,609 | |
| 3 | AMGN |
Amgen Inc
|
6,635 | $2,402,666 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,804 | $2,163,771 | |
| 5 | ABBV |
AbbVie Inc.
|
7,943 | $1,998,776 | |
| 6 | NVS |
Novartis AG
|
8,673 | $1,359,232 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,990 | $287,523 | |
| 8 | PFE |
Pfizer Inc
|
11,614 | $279,665 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,163,771 | 1,804 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,868,052 | 2,031 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,966,664 | 1,830 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,350,510 | 1,770 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,438,232 | 1,845 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $1,542,799 | 1,868 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $1,549,404 | 2,007 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $1,817,062 | 2,051 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $1,856,934 | 2,051 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,777,638 | 2,285 | Shares | Other | 2024-05-10 | |
| 2023-12-31 | $1,331,972 | 2,285 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,252,049 | 2,331 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,114,296 | 2,376 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,004,846 | 2,926 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,156,054 | 3,160 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,015,319 | 3,140 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,018,082 | 3,140 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $708,765 | 2,475 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $683,644 | 2,475 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $571,848 | 2,475 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $613,966 | 2,675 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $485,732 | 2,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $574,056 | 3,400 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $500,751 | 3,383 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $588,256 | 3,583 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $507,437 | 3,658 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||